[1] Curtis MA, Diaz PI, Van Dyke TE. The role of the microbiota in periodontal disease [J]. Periodontology 2000, 2020, 83(1): 14-25. [2] Hong BY, Sobue T, Choquette L, et al. Chemotherapy-induced oral mucositis is associated with detrimental bacterial dysbiosis [J]. Microbiome, 2019, 7(1): 66. [3] Lamont RJ, Koo H, Hajishengallis G. The oral microbiota: dynamic communities and host interactions [J]. Nat Rev Microbiol, 2018, 16(12): 745-759. [4] Kolenbrander PE, Palmer Jr RJ, Rickard AH, et al. Bacterial interactions and successions during plaque development [J]. Periodontology 2000, 2006, 42(1): 47-79. [5] Brennan CA, Garrett WS. Fusobacterium nucleatum-symbiont, opportunist and oncobacterium [J]. Nat Rev Microbiol, 2019, 17(3): 156-166. [6] Kaplan CW, Lux R, Haake SK, et al. The Fusobacterium nucleatum outer membrane protein RadD is an arginine-inhibitable adhesin required for inter-species adherence and the structured architecture of multispecies biofilm [J]. Mol Microbiol, 2009, 71(1): 35-47. [7] Park J, Shokeen B, Haake SK, et al. Characterization of Fusobacterium nucleatum ATCC 23726 adhesins involved in strain-specific attachment to Porphyromonas gingivalis [J]. Int J Oral Sci, 2016, 8(3): 138-144. [8] Kaplan CW, Ma X, Paranjpe A, et al. Fusobacterium nucleatum outer membrane proteins Fap2 and RadD induce cell death in human lymphocytes [J].Infect Immun, 2010, 78(11): 4773-4778. [9] Bhattacharyya S, Ghosh SK, Shokeen B, et al. FAD-I, a Fusobacterium nucleatum cell wall-associated diacylated lipoprotein that mediates human beta defensin 2 induction through Toll-like receptor-1/2 (TLR-1/2) and TLR-2/6 [J]. Infect Immun, 2016, 84(5):1446-1456. [10] Shokeen B, Park J, Duong E, et al. Role of FAD-I in fusobacterial interspecies interaction and biofilm formation [J]. Microorganisms, 2020, 8(1): 70. [11] Guo L, Shokeen B, He X, et al. Streptococcus mutans SpaP binds to RadD of Fusobacterium nucleatum ssp. polymorphum [J]. Mol Oral Microbiol, 2017, 32(5): 355-364. [12] Tong SY, Davis JS, Eichenberger E, et al. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management [J]. Clin Microbiol Rev, 2015, 28(3): 603-661. [13] Lima BP, Hu LI, Vreeman GW, et al. The oral bacterium fusobacterium nucleatum binds staphylococcus aureus and alters expression of the staphylococcal accessory regulator sarA [J]. Microb Ecol, 2019, 78(2): 336-347. [14] Nobile CJ, Johnson AD. Candida albicans biofilms and human disease [J]. Annu Rev Microbiol, 2015, 69: 71-92. [15] Wu T, Cen L, Kaplan C, et al. Cellular components mediating coadherence of Candida albicans and Fusobacterium nucleatum [J]. J Dent Res, 2015, 94(10): 1432-1438. [16] Bor B, Cen L, Agnello M, et al. Morphological and physiological changes induced by contact-dependent interaction between Candida albicans and Fusobacterium nucleatum [J]. Sci Rep, 2016, 6: 27956. [17] Rosen G, Sela MN. Coaggregation of porphyromonas gingivalis and fusobacterium nucleatum PK 1594 is mediated by capsular polysaccharide and lipopolysaccharide [J]. FEMS Microbiol Lett, 2006, 256(2): 304-310. [18] Liu PF, Shi W, Zhu W, et al. Vaccination targeting surface FomA of Fusobacterium nucleatum against bacterial co-aggregation: implication for treatment of periodontal infection and halitosis [J]. Vaccine, 2010, 28(19): 3496-3505. [19] Puth S, Hong SH, Na HS, et al. A built-in adjuvant-engineered mucosal vaccine against dysbiotic periodontal diseases [J]. Mucosal Immunol, 2019, 12(2): 565-579. [20] Lancy P, Dirienzo JM, Appelbaum B, et al. Corncob formation between Fusobacterium nucleatum and Streptococcus sanguis [J]. Infect Immun, 1983, 40(1): 303-309. [21] Edwards AM, Grossman TJ, Rudney JD. Association of a high-molecular weight arginine-binding protein of Fusobacterium nucleatum ATCC 10953 with adhesion to secretory immunoglobulin A and coaggregation with Streptococcus cristatus [J]. Oral Microbiol Immunol, 2007, 22(4): 217-224. [22] Edwards AM, Grossman TJ, Rudney JD. Fusobacterium nucleatum transports noninvasive Streptococcus cristatus into human epithelial cells [J]. Infect Immun, 2006, 74(1): 654-662. [23] Zhang G, Chen R, Rudney JD. Streptococcus cristatus attenuates Fusobacterium nucleatum-induced interleukin-8 expression in oral epithelial cells [J]. J Periodontal Res, 2008, 43(4): 408-416. [24] Zhang G, Rudney JD. Streptococcus cristatus attenuates Fusobacterium nucleatum-induced cytokine expression by influencing pathways converging on nuclear factor-κB [J]. Mol Oral Microbiol, 2011, 26(2): 150-163. [25] Coppenhagen-Glazer S, Sol A, Abed J, et al. Fap2 of Fusobacterium nucleatum is a galactose-inhibitable adhesin involved in coaggregation, cell adhesion, and preterm birth [J]. Infect Immun, 2015, 83(3): 1104-1113. [26] Lima BP, Shi W, Lux R. Identification and characterization of a novel Fusobacterium nucleatum adhesin involved in physical interaction and biofilm formation with Streptococcus gordonii [J]. Microbiologyopen, 2017, 6(3): e00444. [27] Kaplan A, Kaplan CW, He X, et al. Characterization of aid1, a novel gene involved in Fusobacterium nucleatum interspecies interactions [J]. Microb Ecol, 2014, 68(2): 379-387. [28] Rosen G, Nisimov I, Helcer M, et al. Actinobacillus actinomycetemcomitans serotype b lipopolysaccharide mediates coaggregation with Fusobacterium nucleatum [J]. Infect Immun, 2003, 71(6): 3652-3656. [29] Rosen G, Genzler T, Sela MN. Coaggregation of treponema denticola with Porphyromonas gingivalis and Fusobacterium nucleatum is mediated by the major outer sheath protein of Treponema denticola [J]. FEMS Microbiol Lett, 2008, 289(1): 59-66. |